# Biomat USA Inc – FDA Inspection, Oct 2, 2017

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/db3cc610-3c22-420e-bbc8-69926c9a4198
Source feed: FDA_Inspections

> FDA inspection 1028241 of Biomat USA Inc, October 02, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 600 and 606. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1028241
- Company Name: Biomat USA Inc
- Inspection Date: 2017-10-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 815098 - 2013-01-14
- FDA Inspection 724917 - 2011-04-28
- [FDA Inspection 606686 - 2009-07-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/30d06644-4c7d-48a5-ad42-d70f83585363)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/uruaku-a-obasi/8ff0e6f4-da89-4ec0-86f4-7ebf8cf529b8)

Company: https://www.keypedia.com/companies/biomat-usa-inc/d0105a05-f954-4265-9196-ee950cbcb704

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d